Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.94%1.51T | 3.65%1.23T | 14.28%5.07T | -4.04%1.25T | 11.59%1.19T | 36.81%1.44T | 17.28%1.18T | 19.19%4.43T | 52.59%1.3T | 20.45%1.07T |
| Net interest income | 9.05%656.65B | 19.47%626.28B | 24.33%2.34T | 22.41%658.64B | 21.62%553.18B | 28.88%602.18B | 24.67%524.21B | 9.48%1.88T | 21.19%538.07B | 13.65%454.84B |
| -Net interest income | 6.24%1.81T | -2.18%1.71T | 11.51%6.93T | -0.26%1.71T | 12.25%1.76T | 12.40%1.7T | 24.06%1.75T | 64.39%6.21T | 37.43%1.72T | 57.75%1.57T |
| -Including:Interest income from loans and lease | 3.38%1.01T | -4.11%974.67B | 8.38%4.18T | -2.49%1.16T | 12.05%1.03T | 10.72%976.47B | 16.94%1.02T | 51.16%3.86T | 38.27%1.19T | 41.12%919.69B |
| -Including:Interest income from deposits | ---- | ---- | 12.05%650.21B | ---- | ---- | ---- | ---- | 90.70%580.3B | ---- | ---- |
| -Including:Interest income from securities | 5.06%261.64B | 2.68%225.7B | 32.84%935.98B | 11.91%252.74B | 24.08%214.4B | 40.35%249.04B | 71.07%219.8B | 61.09%704.57B | 63.78%225.85B | 108.05%172.79B |
| -Including:Other interest income | 12.74%535.1B | -0.44%512.07B | -6.06%894.73B | -55.97%-613.27B | 8.37%519.04B | 4.71%474.65B | 24.42%514.31B | 104.14%952.43B | -465.08%-393.21B | 83.21%478.97B |
| -Total interest expense | 4.70%1.15T | -11.43%1.09T | 5.94%4.59T | -10.59%1.06T | 8.43%1.21T | 5.03%1.1T | 23.80%1.23T | 110.14%4.33T | 46.37%1.18T | 87.36%1.12T |
| -Including:Interest expense for deposit | 6.08%418.25B | -4.83%414.05B | 1.89%2.23T | -3.27%941.67B | 10.78%459.29B | -5.55%394.28B | 13.47%435.06B | 107.25%2.19T | 65.53%973.52B | 74.22%414.59B |
| -Including:Interest expense for short termdebt | ---- | ---- | 0.40%160.91B | ---- | ---- | ---- | ---- | 153.71%160.26B | ---- | ---- |
| -Including:Interest expense for long term debt and capital securities | ---- | ---- | 15.28%584.62B | ---- | ---- | ---- | ---- | 47.83%507.12B | ---- | ---- |
| -Including:Other interest expense | 3.93%731.36B | -15.06%672.11B | 6.90%777.29B | -21.42%-1.47T | 7.04%751.46B | 12.06%703.69B | 30.33%791.31B | 124.60%727.15B | -160.93%-1.21T | 96.10%702.02B |
| Non interest income | 1.99%853.32B | -8.91%601.53B | 6.87%2.73T | -22.63%592.08B | 4.16%638.92B | 43.16%836.65B | 12.00%660.4B | 27.53%2.55T | 86.59%765.26B | 26.05%613.42B |
| -Fees and commissions | 13.57%433.38B | 6.36%401.52B | 5.28%1.57T | -8.79%391.23B | 12.35%418.56B | 6.88%381.61B | 13.80%377.51B | 21.58%1.49T | 34.43%428.91B | 18.15%372.57B |
| -Other non interest income | 93.49%335.72B | -45.19%142.39B | -65.81%217.76B | -1,987.52%-518.43B | 412.79%302.9B | -21.07%173.51B | -21.42%259.77B | 25.35%636.93B | 135.92%27.47B | 288.01%59.07B |
| -Gain loss on sale of assets | --0 | --0 | 1,963.85%1.12T | 1,963.85%1.12T | --0 | --0 | --0 | -79.22%54.43B | -79.22%54.43B | --0 |
| -Trading gain /loss | -70.08%84.22B | 149.18%57.62B | -149.01%-181.88B | -258.76%-403.99B | -145.41%-82.54B | 3,626.79%281.52B | 131.82%23.13B | 6,154.36%371.13B | 369.74%254.47B | -10.33%181.78B |
| Credit losses provision | 73.45%-14.52B | -159.04%-75.65B | -25.73%-344.5B | -33.82%-186.48B | -115.97%-74.12B | 2.98%-54.7B | 33.55%-29.2B | -30.35%-274B | -40.61%-139.35B | -22.63%-34.32B |
| Non interest expense | -18.71%722.53B | 8.88%725.03B | 8.37%3T | 3.27%888.57B | -10.26%554.16B | 35.89%888.87B | 5.05%665.92B | 15.07%2.77T | 42.75%860.44B | 6.52%617.52B |
| Selling and administrative expenses | 8.40%629.11B | 1.23%599.67B | 5.28%2.4T | -3.30%628.98B | 9.36%600.23B | 6.07%580.34B | 10.71%592.41B | 27.81%2.28T | 82.06%650.46B | 17.99%548.85B |
| -General and administrative expense | 8.40%629.11B | 1.23%599.67B | 5.28%2.4T | -3.30%628.98B | 9.36%600.23B | 6.07%580.34B | 10.71%592.41B | 27.81%2.28T | 82.06%650.46B | 17.99%548.85B |
| Other non-interest expense | -69.72%93.42B | 70.52%125.35B | 22.93%595.57B | 23.63%259.59B | -167.09%-46.07B | 188.34%308.53B | -25.60%73.51B | 14.46%484.47B | 320.43%209.98B | -40.04%68.67B |
| Income from associates and other participating interests | 52.61%21.87B | 78.99%56.19B | -107.64%-5.5B | -118.30%-76.02B | -65.10%24.79B | -24.25%14.33B | 86.10%31.4B | 29.73%72B | -45.37%-34.82B | 159.50%71.04B |
| Special income (charges) | -144.35%-887M | 34.92%-1.76B | 84.72%-18.81B | -11.53%-12.17B | 96.74%-3.57B | 78.90%-363M | -140.59%-2.71B | -97.01%-123.05B | 81.81%-10.91B | -10,019.63%-109.29B |
| Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---7.08B | ---- | ---- |
| Less:Impairment of capital assets | ---- | ---- | -48.51%7.05B | ---- | ---- | ---- | ---- | -76.80%13.7B | ---- | ---- |
| Less:Other special charges | 144.35%887M | -34.92%1.76B | 42.63%11.75B | 104.92%5.12B | -96.74%3.57B | -78.90%363M | 140.59%2.71B | 141.43%8.24B | -11,200.21%-103.9B | 10,019.63%109.29B |
| Gain on sale of business | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---108.19B | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 55.90%793.9B | -7.06%481.57B | 26.64%1.7T | -66.06%87.5B | 54.71%585.05B | 42.09%509.22B | 48.90%518.18B | 22.20%1.34T | 277.24%257.81B | 23.80%378.16B |
| Income tax | 53.93%235.17B | -29.39%102.24B | 37.31%513.07B | -49.71%43.04B | 56.30%172.45B | 89.89%152.78B | 48.83%144.8B | 32.43%373.66B | 234.02%85.59B | 75.75%110.33B |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 56.75%558.73B | 1.59%379.33B | 22.52%1.19T | -74.19%44.45B | 54.06%412.6B | 28.25%356.45B | 48.92%373.38B | 18.66%968.69B | 303.16%172.22B | 10.36%267.82B |
| Net Income continuous operations | 56.75%558.73B | 1.59%379.33B | 22.52%1.19T | -74.19%44.45B | 54.06%412.6B | 28.25%356.45B | 48.92%373.38B | 18.66%968.69B | 303.16%172.22B | 10.36%267.82B |
| Noncontrolling interests | -19.21%2.12B | 20.09%2.43B | 54.72%8.88B | 15.01%2.43B | 23.76%1.8B | 596.98%2.63B | -25.10%2.03B | -45.23%5.74B | -27.10%2.11B | -30.33%1.45B |
| Net income attributable to the company | 57.31%556.61B | 1.49%376.9B | 22.33%1.18T | -75.30%42.03B | 54.22%410.8B | 27.07%353.82B | 49.73%371.36B | 19.50%962.95B | 327.18%170.11B | 10.71%266.37B |
| Net income attributable to common stockholders | 57.31%556.61B | 1.49%376.9B | 22.33%1.18T | -75.30%42.03B | 54.22%410.8B | 27.07%353.82B | 49.73%371.36B | 19.50%962.95B | 327.18%170.11B | 10.71%266.37B |
| Diluted earnings per share | 59.90%144.57 | 3.29%97.46 | 24.86%301.55 | -73.29%11.56 | 57.59%105.22 | 29.95%90.41 | 52.45%94.36 | 22.71%241.52 | 317.49%43.28 | 13.73%66.77 |
| Basic earnings per share | 59.92%144.54 | 3.29%97.44 | 24.86%301.48 | -73.28%11.56 | 57.60%105.2 | 29.95%90.38 | 52.46%94.34 | 22.72%241.45 | 317.53%43.27 | 13.73%66.75 |
| Dividend per share | 30.00%78 | --0 | 35.56%122 | 37.78%62 | --0 | 33.33%60 | --0 | 12.50%90 | 8.00%45 | --0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |